Heidi Hagen Joins Aastrom Board of Directors

Aastrom Biosciences (Nasdaq: ASTM ), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, announced today that Heidi Hagen has joined the Aastrom Board of Directors. Ms. Hagen is global chief operating officer at Sotio LLC, a biotechnology company developing new therapies for